A MultiCtr,OL,dosageranging study in early,untreated or stably treated subjects with Parkinson's PD to determine the safety,tolerability and PK of inj ofSER-214administered subcu once a week for two weeks after 0-2 weeks of dose titration.
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Serina Therapeutics, Inc.
Start Date
January 1, 2016
End Date
October 31, 2017
Administered By
Neurology, Movement Disorders
Awarded By
Serina Therapeutics, Inc.
Start Date
January 1, 2016
End Date
October 31, 2017